Package 50242-145-01

Brand: perjeta

Generic: pertuzumab
NDC Package

Package Facts

Identity

Package NDC 50242-145-01
Digits Only 5024214501
Product NDC 50242-145
Description

1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2012-06-08
Brand perjeta
Generic pertuzumab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "bef4af16-e063-40ce-a5b5-585d3311df2b", "openfda": {"nui": ["N0000175661", "N0000020008"], "unii": ["K16AIQ8CTM"], "rxcui": ["1298948", "1298953"], "spl_set_id": ["17f85d17-ab71-4f5b-9fe3-0b8c822f69ff"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01)  / 14 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-145-01", "marketing_start_date": "20120608"}], "brand_name": "PERJETA", "product_id": "50242-145_bef4af16-e063-40ce-a5b5-585d3311df2b", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-145", "generic_name": "Pertuzumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PERJETA", "active_ingredients": [{"name": "PERTUZUMAB", "strength": "30 mg/mL"}], "application_number": "BLA125409", "marketing_category": "BLA", "marketing_start_date": "20120608", "listing_expiration_date": "20261231"}